Involvement that fits between synopsis and final protocol.
You have one window to shape your protocol before it's fixed, and it's short. Here's what we do inside it.
What you send
The protocol synopsis, the visit schedule and the draft participant information sheet, in whatever state they're in. If your CRO is drafting them, the CRO can send them.
What comes back
What members raised, point by point, with how many raised it and who; your decisions on what changes and what doesn't; and a report written to answer the IRAS public involvement question and to give you the CTIS Part I and Part II wording. The Health Research Authority's checklist says participant information developed without public involvement "will not normally receive a favourable opinion from REC", so this is the document the committee is looking for.
How long, and what it costs
A £7,500 pilot covers the information sheet and visit schedule. When we already hold your condition, that's usually about ten working days from documents sent to report received, and about half a day of your team's time across the whole piece: a short briefing call, sending the documents, and deciding what changes. If we have to recruit your condition first, allow about four weeks, and we tell you that before you commit. We quote the exact working days before anything starts, and we hold to them.
First-in-human and Phase I
If your first clinical trial is in healthy volunteers, say so in the panel check and we'll tell you honestly whether the panel helps. If it's in patients, the information sheet and the visit burden are exactly what members are good at.
Rare disease
For a condition with a few hundred UK patients, we don't pretend to hold 150 of them. We build a small group to order, patients or caregivers, and we'll report on a group as small as ten. Recruiting usually takes about four weeks, and the build is part of your quote, not charged on top.
Confidential
Your material stays inside our platform, with download and browser screenshots blocked, and members sign your confidentiality wording if you want.
Safety
Members are told when they join how to report a side effect to their doctor and to the MHRA's Yellow Card scheme. Every survey answer, voice note and video diary is screened by our team before it reaches you. Anything that mentions a side effect, a product complaint or a safety concern about a named medicine is passed to your pharmacovigilance contact within one working day, and we close every piece of work with a reconciliation log of what was passed on and when.